Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Sepsis and Septic Shock
NCT05572060Unknown
- Sponsor
- Assiut University
- Start
- Dec 2022
- Primary completion
- Dec 2024
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of metformin in sepsis and septic shock (3 arms), sponsored by Assiut University. Primary endpoint: 28 day Mortality. Status: unknown.
02
Drugs
metformin
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT05572060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05572060.